GlobalFoundries Inc. (NASDAQ:GFS) reported that its Chief Legal Officer, Azar Samak L, completed a sale of 500 ordinary shares on March 26, 2026. The shares were sold at $45.99 apiece, producing a total transaction value of $22,995. The sale was disclosed on a Form 4 and was executed pursuant to a Rule 10b5-1 trading plan that the reporting person had put in place prior to the offering.
At the time of the transaction, GlobalFoundries shares were trading at $41.30. An InvestingPro analysis cited alongside the filing indicates a Fair Value estimate of $43.98 for the stock. InvestingPro Tips cited in the filing also note that the semiconductor company has generated a 23% year-to-date return and that the balance sheet shows more cash than debt.
Following the reported sale, Azar Samak L directly holds 18,994 shares of GlobalFoundries.
These insider developments arrive amid several notable corporate and market actions involving GlobalFoundries. Mubadala Technology Investment Company priced a secondary offering of 20 million ordinary shares at $42.00 per share. The offering was conducted by Mubadala Technology Investment Company and did not involve GlobalFoundries selling any shares directly; accordingly, the company will not receive proceeds from that offering.
Separately, a unit of Mubadala Investment Co. sold $840 million in GlobalFoundries shares. That offering was reportedly four times oversubscribed, a detail included in the disclosures accompanying the transaction.
On the legal front, GlobalFoundries has filed patent infringement actions against Tower Semiconductor in both the U.S. International Trade Commission and the United States District Court for the Western District of Texas. The complaints allege infringement of 11 U.S. patents across a set of technologies identified in the filings.
In addition to capital markets and litigation activity, there was a governance-related appointment announced: USA Rare Earth named Dr. Thomas Caulfield, the Executive Chairman of GlobalFoundries, to its Board of Directors. The filing notes that Dr. Caulfield previously guided GlobalFoundries through its initial public offering in 2021.
Taken together, the insider sale, the Mubadala-led share transactions, the pending patent litigation, and the board appointment represent a cluster of strategic, legal, and market events that investors will likely track as they assess GlobalFoundries’ near-term trajectory.